Skip to content

Strength Training for Skeletal Muscle Adaptation After Stroke

Strength Training for Skeletal Muscle Adaptation After Stroke

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00827827
Enrollment
38
Registered
2009-01-23
Start date
2009-04-01
Completion date
2018-06-06
Last updated
2018-07-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Keywords

Stroke, Exercise, Strength Training, Skeletal Muscle, Insulin Sensitivity

Brief summary

Chronically disabled stroke survivors experience accelerated skeletal muscle atrophy and other detrimental changes to muscle and surrounding tissues on the paretic side. This unilateral tissue-level damage contributes to worsening disability and insulin resistance. This VA Merit Award will advance the investigators' understanding of the potential for strength training (ST) to reverse stroke-related muscle abnormalities to improve metabolic health, strength, and function. It will be the first study to thoroughly investigate the effects of ST on muscle atrophy, intramuscular fat, muscle fiber characteristics, capillary density and insulin sensitivity after stroke.

Detailed description

This study investigates the hypothesis that a novel, high intensity, high repetition ST program will improve abnormalities in paretic and non-paretic leg muscle volume and composition compared to an attention-matched control regimen of supervised stretching over a 3-month intervention period in those disabled by stroke. The investigators further hypothesize that ST-induced skeletal muscle adaptation will translate into improved insulin sensitivity, strength, and function in this population. The specific objectives are to: 1) Determine the effects ST compared to a control intervention on paretic and non-paretic abnormalities in skeletal muscle volume, intramuscular fat, muscle fiber distribution, muscle capillary density, and muscle inflammation in chronically disabled stroke survivors. 2) Determine the effects ST compared to a control intervention on insulin sensitivity in stroke survivors, and whether structural and cellular skeletal muscle mechanisms contribute to improvements in insulin sensitivity after ST. 3) Determine the effects ST compared to a control intervention on physical function (strength, walking speed and balance) in stroke survivors, and whether structural skeletal muscle mechanisms predict ST-induced functional improvement. The project design consists of 4 phases over 5 months for stroke participants enrolled in either of the two intervention arms (ST vs. CONTROL). During phase 1 the investigators will screen and consent chronic stroke patients with residual gait deficits. Phase 2 (3 weeks) will consist of baseline testing that includes dual energy X-ray absorptiometry (DEXA) scanning, bilateral CT scanning of the legs, bilateral vastus lateralis muscle biopsies, strength testing, timed walks, balance measurements, oral glucose tolerance testing, and hyperglycemic clamp testing. Following completion of baseline testing, volunteers are to be randomized to ST or the CONTROL group. Phase 3 (Intervention Phase, 3 months) will begin with 2 sessions of acclimatization for those assigned to the ST group. ST will then be progressed to 2 sets of 20 repetitions on each leg on each machine (Keiser Leg Press, Leg Extension, Leg Curl) with gradual increases in resistance over 3 months. Those in the CONTROL group will receive equal exposure to health care personnel in the Baltimore VA Exercise facility, performing a full battery of upper and lower body passive and active stretching exercises at each intervention session. In Phase 4 all baseline testing and laboratory analyses will be repeated. Developing evidence-based therapies to combat skeletal muscle deterioration is highly relevant for chronically disabled stoke survivors. There is mounting evidence that current models of post-stroke rehabilitation are not optimal for maximizing recovery of muscle mass, strength, and metabolic health. The proposed research will develop new insight into the utility of progressive ST for reversing detrimental changes to gross muscle composition, muscle molecular phenotype, muscle inflammation, and muscle capillarization. Changes to any or all of these muscle parameters should have measurable impact on both whole body insulin sensitivity and function. Collectively, the results from this trial may change the current standard of care for stroke survivors by providing evidenced reasons for augmenting physical therapists' treatments, allowing more intense and diverse therapy sessions for maintenance of skeletal muscle.

Interventions

OTHERExercise- Strength Training

3x per week lower-extremity ST lasting approximately 45 minutes to 1 hour.

OTHERExercise- Stretching Control

3x per week upper and lower body stretching mixed with active and passive range of motion exercises

Sponsors

VA Office of Research and Development
Lead SponsorFED

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
40 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

* Stroke greater than 6 months prior with residual hemiparetic gait in women or men aged 40-85 years * Completion of all regular post-stroke physical therapy * Adequate language and neurocognitive function to participate in testing and training and to give adequate informed consent

Exclusion criteria

* Alcohol consumption greater than 3 oz. liquor, or 3 x 4 oz glasses of wine, or 3 x 12 oz. beers per day, by self-report * clinical history of: * unstable angina * recent (less than 3 months) myocardial infarction or congestive heart failure (NYHA category II) * hemodynamically significant valvular dysfunction * peripheral arterial occlusive disease (PAOD) with claudication * major orthopedic, chronic pain, or non-stroke neuromuscular disorders restricting exercise * pulmonary or renal failure * poorly controlled hypertension (greater than 190/110) * recent hospitalization for severe disease or surgery * severe or global receptive aphasia which confounds reliable testing and training * Allergy to lidocaine * Known muscle disorder * Taking Coumadin or Lovenox (contraindication for muscle biopsies) * Dementia * Untreated major depression

Design outcomes

Primary

MeasureTime frameDescription
Change in 1-RM Muscle Strength (Leg Extension, Paretic Side)Baseline, 3 Months
Change in 1-repetition Maximum (RM) Muscle Strength (Leg Press, Paretic Side)Baseline, 3 months
Change in 1-RM Muscle Strength (Leg Press, Non-Paretic Side)Baseline, 3 months
Change in 1-RM Muscle Strength (Leg Extension, Non-Paretic Side)Baseline, 3 Months
Change in Leg Muscle Endurance (Paretic Side)Baseline, 3 MonthsTests how training impacts the total number of submaximal repetitions a participant can perform according to standardized cadence (at the same absolute level of resistance, pre and post).
Change in Leg Muscle Endurance (Non-Paretic Side)Baseline, 3 monthsTests how training impacts the total number of submaximal repetitions a participant can perform according to standardized cadence (at the same absolute level of resistance, pre and post).
Change in 6-minute Walk DistanceBaseline, 3 Months
Change in 10 Meter Walking Speed (Self-Selected)Baseline, 3 months
Change in 10 Meter Walking Speed (Fastest)Baseline, 3 Months
Change in Peak Aerobic Capacity (VO2 Peak)Baseline, 3 Months
Change in Berg Balance ScaleBaseline, 3 monthsThis measure is a 14 item scale, with each item scored (0-4) and summed for a maximum score of 56 points. Range is 0-56 and higher values represent a better outcome.
Change in Paretic Limb Step Time (Self-Selected)Baseline, 3 monthsThis and other measures come from Instrumented Walkway (Gait Rite)
Change in Paretic Limb Step Time (Fastest)Baseline, 3 MonthsThis and other measures come from Instrumented Walkway (Gait Rite)
Change in Non-Paretic Limb Step Time (Self-Selected)Baseline, 3 monthsThis and other measures come from Instrumented Walkway (Gait Rite)
Change in Non-Paretic Limb Step Time (Fastest)Baseline, 3 MonthsThis and other measures come from Instrumented Walkway (Gait Rite)
Change in Paretic Limb Step Length (Self-Selected)Baseline, 3 MonthsThis and other measures come from Instrumented Walkway (Gait Rite)
Change in Paretic Limb Step Length (Fastest)Baseline, 3 monthsThis and other measures come from Instrumented Walkway (Gait Rite)
Change in Non-Paretic Limb Step Length (Self-Selected)Baseline, 3 MonthsThis and other measures come from Instrumented Walkway (Gait Rite)
Change in Non-Paretic Limb Step Length (Fastest)Baseline, 3 MonthsThis and other measures come from Instrumented Walkway (Gait Rite)

Countries

United States

Participant flow

Participants by arm

ArmCount
Strength Training
Participants in this group undergo lower-extremity strength training on three pneumatic resistance machines (Keiser Leg Press, Keiser Leg Extension, and Keiser Leg Curl). Training sessions happen 3 times per week (M,W,F) and last approximately 45 minutes to 1 hour. Participants in this group exercise each limb individually to account for the large discrepancies in strength between legs in stroke survivors. Exercise- Strength Training: 3x per week lower-extremity ST lasting approximately 45 minutes to 1 hour.
22
Stretching Control
Participants in this group receive equal exposure to study staff compared with the experimental ST group (approximately 45 minutes to 1 hour 3 times per week). Exercise sessions for this group involve a full battery of active and passive...upper and lower body...stretching and range of motion exercises performed on raised padded tables. Exercise- Stretching Control: 3x per week upper and lower body stretching mixed with active and passive range of motion exercises
16
Total38

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyAnother cerebrovascular accident (CVA)10
Overall StudyBurned with water at home10
Overall StudyFall at home- hospitalization10
Overall StudyGout10
Overall StudyLost to Follow-up30
Overall StudyTransportation issues10

Baseline characteristics

CharacteristicStretching ControlStrength TrainingTotal
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
2 Participants3 Participants5 Participants
Age, Categorical
Between 18 and 65 years
14 Participants19 Participants33 Participants
Age, Continuous55.2 years
STANDARD_DEVIATION 8.7
56.9 years
STANDARD_DEVIATION 11.5
56.2 years
STANDARD_DEVIATION 10.3
Region of Enrollment
United States
16 participants22 participants38 participants
Sex: Female, Male
Female
4 Participants6 Participants10 Participants
Sex: Female, Male
Male
12 Participants16 Participants28 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
3 / 229 / 16
serious
Total, serious adverse events
2 / 222 / 16

Outcome results

Primary

Change in 10 Meter Walking Speed (Fastest)

Time frame: Baseline, 3 Months

Population: All participants for whom 10 Meter walking Speed (Fastest-Safe) was recorded at Baseline and 3 months

ArmMeasureValue (MEAN)Dispersion
Strength TrainingChange in 10 Meter Walking Speed (Fastest)0.24 meters/ secondStandard Error 0.1
Stretching ControlChange in 10 Meter Walking Speed (Fastest)0.09 meters/ secondStandard Error 0.08
Primary

Change in 10 Meter Walking Speed (Self-Selected)

Time frame: Baseline, 3 months

Population: All participants for whom 10 Meter walking Speed (Self-Selected) was recorded at Baseline and 3 months

ArmMeasureValue (MEAN)Dispersion
Strength TrainingChange in 10 Meter Walking Speed (Self-Selected)0.16 meters/ secondStandard Error 0.09
Stretching ControlChange in 10 Meter Walking Speed (Self-Selected)0.03 meters/ secondStandard Error 0.06
Primary

Change in 1-repetition Maximum (RM) Muscle Strength (Leg Press, Paretic Side)

Time frame: Baseline, 3 months

Population: All participants for whom strength measurements were recorded at Baseline and 3 months

ArmMeasureValue (MEAN)Dispersion
Strength TrainingChange in 1-repetition Maximum (RM) Muscle Strength (Leg Press, Paretic Side)126.1 lbsStandard Error 22.2
Stretching ControlChange in 1-repetition Maximum (RM) Muscle Strength (Leg Press, Paretic Side)11.3 lbsStandard Error 14.6
Primary

Change in 1-RM Muscle Strength (Leg Extension, Non-Paretic Side)

Time frame: Baseline, 3 Months

Population: All participants for whom strength measurements were recorded at Baseline and 3 months

ArmMeasureValue (MEAN)Dispersion
Strength TrainingChange in 1-RM Muscle Strength (Leg Extension, Non-Paretic Side)20.8 lbsStandard Error 0.4
Stretching ControlChange in 1-RM Muscle Strength (Leg Extension, Non-Paretic Side)0.4 lbsStandard Error 2.6
Primary

Change in 1-RM Muscle Strength (Leg Extension, Paretic Side)

Time frame: Baseline, 3 Months

Population: All participants for whom strength measurements were recorded at Baseline and 3 months

ArmMeasureValue (MEAN)Dispersion
Strength TrainingChange in 1-RM Muscle Strength (Leg Extension, Paretic Side)28.6 lbsStandard Error 4.3
Stretching ControlChange in 1-RM Muscle Strength (Leg Extension, Paretic Side)3.4 lbsStandard Error 2.4
Primary

Change in 1-RM Muscle Strength (Leg Press, Non-Paretic Side)

Time frame: Baseline, 3 months

Population: All participants for whom strength measurements were recorded at Baseline and 3 months

ArmMeasureValue (MEAN)Dispersion
Strength TrainingChange in 1-RM Muscle Strength (Leg Press, Non-Paretic Side)93.2 lbsStandard Error 26.1
Stretching ControlChange in 1-RM Muscle Strength (Leg Press, Non-Paretic Side)22.7 lbsStandard Error 16.4
Primary

Change in 6-minute Walk Distance

Time frame: Baseline, 3 Months

Population: All participants for whom 6-minute walk distance was recorded at Baseline and 3 months

ArmMeasureValue (MEAN)Dispersion
Strength TrainingChange in 6-minute Walk Distance132.3 feetStandard Error 48.3
Stretching ControlChange in 6-minute Walk Distance-2.1 feetStandard Error 21.6
Primary

Change in Berg Balance Scale

This measure is a 14 item scale, with each item scored (0-4) and summed for a maximum score of 56 points. Range is 0-56 and higher values represent a better outcome.

Time frame: Baseline, 3 months

Population: All participants for whom a Berg Score was recorded at Baseline and 3 months

ArmMeasureValue (MEAN)Dispersion
Strength TrainingChange in Berg Balance Scale0.3 Scores on a scaleStandard Error 0.6
Stretching ControlChange in Berg Balance Scale-0.1 Scores on a scaleStandard Error 0.5
Primary

Change in Leg Muscle Endurance (Non-Paretic Side)

Tests how training impacts the total number of submaximal repetitions a participant can perform according to standardized cadence (at the same absolute level of resistance, pre and post).

Time frame: Baseline, 3 months

Population: All participants for whom muscle endurance measurements were recorded at Baseline and 3 months

ArmMeasureValue (MEAN)Dispersion
Strength TrainingChange in Leg Muscle Endurance (Non-Paretic Side)27.5 repetitionsStandard Error 5
Stretching ControlChange in Leg Muscle Endurance (Non-Paretic Side)1.8 repetitionsStandard Error 1.8
Primary

Change in Leg Muscle Endurance (Paretic Side)

Tests how training impacts the total number of submaximal repetitions a participant can perform according to standardized cadence (at the same absolute level of resistance, pre and post).

Time frame: Baseline, 3 Months

Population: All participants for whom muscle endurance measurements were recorded at Baseline and 3 months

ArmMeasureValue (MEAN)Dispersion
Strength TrainingChange in Leg Muscle Endurance (Paretic Side)27.4 repetitionsStandard Error 4.5
Stretching ControlChange in Leg Muscle Endurance (Paretic Side)2.0 repetitionsStandard Error 2.1
Primary

Change in Non-Paretic Limb Step Length (Fastest)

This and other measures come from Instrumented Walkway (Gait Rite)

Time frame: Baseline, 3 Months

Population: All participants for whom measurement was recorded at Baseline and 3 months

ArmMeasureValue (MEAN)Dispersion
Strength TrainingChange in Non-Paretic Limb Step Length (Fastest)4.6 cmStandard Error 1.9
Stretching ControlChange in Non-Paretic Limb Step Length (Fastest)-0.4 cmStandard Error 3
Primary

Change in Non-Paretic Limb Step Length (Self-Selected)

This and other measures come from Instrumented Walkway (Gait Rite)

Time frame: Baseline, 3 Months

Population: All participants for whom measurement was recorded at Baseline and 3 months

ArmMeasureValue (MEAN)Dispersion
Strength TrainingChange in Non-Paretic Limb Step Length (Self-Selected)3.8 cmStandard Error 1.4
Stretching ControlChange in Non-Paretic Limb Step Length (Self-Selected)0.3 cmStandard Error 2.1
Primary

Change in Non-Paretic Limb Step Time (Fastest)

This and other measures come from Instrumented Walkway (Gait Rite)

Time frame: Baseline, 3 Months

Population: All participants for whom measurement was recorded at Baseline and 3 months

ArmMeasureValue (MEAN)Dispersion
Strength TrainingChange in Non-Paretic Limb Step Time (Fastest)-0.01 secondsStandard Error 0.02
Stretching ControlChange in Non-Paretic Limb Step Time (Fastest)-0.01 secondsStandard Error 0.01
Primary

Change in Non-Paretic Limb Step Time (Self-Selected)

This and other measures come from Instrumented Walkway (Gait Rite)

Time frame: Baseline, 3 months

Population: All participants for whom measurement was recorded at Baseline and 3 months

ArmMeasureValue (MEAN)Dispersion
Strength TrainingChange in Non-Paretic Limb Step Time (Self-Selected)-0.01 secondsStandard Error 0.02
Stretching ControlChange in Non-Paretic Limb Step Time (Self-Selected)-0.07 secondsStandard Error 0.05
Primary

Change in Paretic Limb Step Length (Fastest)

This and other measures come from Instrumented Walkway (Gait Rite)

Time frame: Baseline, 3 months

Population: All participants for whom measurement was recorded at Baseline and 3 months

ArmMeasureValue (MEAN)Dispersion
Strength TrainingChange in Paretic Limb Step Length (Fastest)3.8 cmStandard Error 2.1
Stretching ControlChange in Paretic Limb Step Length (Fastest)0.9 cmStandard Error 2.7
Primary

Change in Paretic Limb Step Length (Self-Selected)

This and other measures come from Instrumented Walkway (Gait Rite)

Time frame: Baseline, 3 Months

Population: All participants for whom measurement was recorded at Baseline and 3 months

ArmMeasureValue (MEAN)Dispersion
Strength TrainingChange in Paretic Limb Step Length (Self-Selected)4.0 cmStandard Error 1.5
Stretching ControlChange in Paretic Limb Step Length (Self-Selected)1.1 cmStandard Error 2.8
Primary

Change in Paretic Limb Step Time (Fastest)

This and other measures come from Instrumented Walkway (Gait Rite)

Time frame: Baseline, 3 Months

Population: All participants for whom measurement was recorded at Baseline and 3 months

ArmMeasureValue (MEAN)Dispersion
Strength TrainingChange in Paretic Limb Step Time (Fastest)0.00 secondsStandard Error 0.03
Stretching ControlChange in Paretic Limb Step Time (Fastest)0.00 secondsStandard Error 0.02
Primary

Change in Paretic Limb Step Time (Self-Selected)

This and other measures come from Instrumented Walkway (Gait Rite)

Time frame: Baseline, 3 months

Population: All participants for whom measurement was recorded at Baseline and 3 months

ArmMeasureValue (MEAN)Dispersion
Strength TrainingChange in Paretic Limb Step Time (Self-Selected)-0.04 secondsStandard Error 0.03
Stretching ControlChange in Paretic Limb Step Time (Self-Selected)-0.03 secondsStandard Error 0.03
Primary

Change in Peak Aerobic Capacity (VO2 Peak)

Time frame: Baseline, 3 Months

Population: All participants for whom Peak Aerobic Capacity was recorded during Graded Treadmill Test at Baseline and 3 months

ArmMeasureValue (MEAN)Dispersion
Strength TrainingChange in Peak Aerobic Capacity (VO2 Peak)1.2 mls/kg/minStandard Error 0.6
Stretching ControlChange in Peak Aerobic Capacity (VO2 Peak)-0.4 mls/kg/minStandard Error 0.5

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026